American College of Cardiology - Without a doubt, the top news of 2020 was the COVID-19 pandemic. From the beginning, ACC was at the forefront of generating clinical guidance,...
# ACC20
MedPageToday - Repurposed as drug, tested in randomized...
-
Sodium nitrite no help in OHCA resuscitation, SNOCAT researchers reported at #ACC20. Full manuscript now out in @JAMA_current https://t.co/Xjes7CwffW
FDA Approves Vericiguat for High-risk Patients With HF
posted 4 days
TCTMD - The approval, the first from the FDA in 2021, follows the positive results from the VICTORIA trial presented last year at...
-
.@US_FDA approves vericiguat for high-risk patients with HF. The approval, the first from the FDA in 2021, follows the positive results from the VICTORIA trial presented last year at #ACC20. @TCTMD @michaelTCTMD: https://t.co/nPx5o12Cdt
Although #COVID19 dominated the 2020 news cycle, ACC covered much more clinical news on #CVD. Hot clinical trials like RIVER, DAPA-CKD, and made headlines from major meetings, including #ACC20 Virtual. Read on to see top 2020 ACC news stories: https://t.co/9IZ1XOfMrp https://t.co/9IZ1XOfMrp